Dehydroandrographolide may be a potential therapeutic drug for ALI induced by coronavirus disease 19 by inhibiting the Akt/Nrf2 pathway (Pu et al. 2023). The gene discussed is AKT1; the disease is acute respiratory distress syndrome.